ACR 163: Colorectal Cancer Awareness Month.
- Session Year: 2017-2018
- House: Assembly
- Latest Version Date: 2018-04-13
This bill would designate March 2018 as Colorectal Cancer Awareness Month in California.
This bill would designate March 2018 as Colorectal Cancer Awareness Month in California.
This bill would designate March 2018 as Colorectal Cancer Awareness Month in California.
This bill would designate March 2018 as Colorectal Cancer Awareness Month in California.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths of Californians, with 14,400 new cases and 5,300 deaths expected in 2018; and
WHEREAS, Colorectal cancer is treatable, curable, and, in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2016, only 73 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, FOBTs and fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 39 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believes that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2018 as Colorectal Cancer Awareness Month in California; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths of Californians, with 14,400 new cases and 5,300 deaths expected in 2018; and
WHEREAS, Colorectal cancer is treatable, curable, and, in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2016, only 73 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, FOBTs and fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 39 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believes that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2018 as Colorectal Cancer Awareness Month in California; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths in of Californians, with 14,604 14,400 new cases and 5,195 5,300 deaths expected in 2014; 2018; and
WHEREAS, Colorectal cancer is treatable, curable, and and, in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, There are now more than one million survivors of colorectal cancer in the United States; andWHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2014, 2016, only 55 73 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, FOBTs and fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 42 39 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean men and Hmong women, and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, Kampuchean, and Hawaiian Pacific Islander men, and the second most common cancer among Chinese, Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hawaiian Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 encourages and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believes that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2018 as Colorectal Cancer Awareness Month in California; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,604 new cases and 5,195 deaths in 2014; and
WHEREAS, Colorectal cancer is treatable, curable, and in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, There are now more than one million survivors of colorectal cancer in the United States; and
WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2014, only 55 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, FOBTs and fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 42 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean men and Hmong women, the second most common cancer among Hispanic, Japanese, South Asian, Kampuchean, and Hawaiian men, and the second most common cancer among Chinese, Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hawaiian women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, C4 encourages Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believes that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2018 as Colorectal Cancer Awareness Month in California; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Apr 13, 2018 | Chaptered by Secretary of State - Res. Chapter 32, Statutes of 2018. |
| Apr 13, 2018 | Enrolled and filed with the Secretary of State at 3:30 p.m. |
| Apr 9, 2018 | In Assembly. Ordered to Engrossing and Enrolling. |
| Apr 9, 2018 | Adopted and to Assembly. |
| Apr 5, 2018 | Ordered to special consent calendar. |
| Apr 4, 2018 | From committee: Ordered to third reading. |
| Mar 20, 2018 | In Senate. To Com. on RLS. |
| Mar 19, 2018 | Coauthors revised. |
| Feb 26, 2018 | From committee: Be adopted. Ordered to Third Reading. (Ayes 8. Noes 0.) (February 26). |
| Feb 22, 2018 | Re-referred to Com. on RLS. |
| Feb 21, 2018 | From committee chair, with author's amendments: Amend, and re-refer to Com. on RLS. Amended. |
| Feb 5, 2018 | Referred to Com. on RLS. |
| Jan 26, 2018 | From printer. |
| Jan 25, 2018 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Apr 9, 2018 | Special Consent ACR163 | Senate Floor |
Passed |
|
| Feb 26, 2018 | Be adopted. To third reading. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| American Cancer Society Cancer Action Network | ** Support | Apr 4, 2018 |
| California Colorectal Cancer Coalition | ** Support | Apr 4, 2018 |
| California Life Sciences Association | ** Support | Apr 4, 2018 |
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | ACR 163 |
THIRD READING
Bill No: ACR 163
Amended: 2/21/18 in Assembly
ASSEMBLY FLOOR: Read and adopted, 3/19/18
SUBJECT: Colorectal Cancer Awareness Month
SOURCE: American Cancer Society Cancer Action Network
California Colorectal Cancer Coalition
DIGEST:
This resolution designates March 2018 as Colorectal Cancer Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- Colorectal cancer is the second leading cause of cancer deaths of Californians, with 14,400 new cases and 5,300 deaths expected in 2018. With proper screening, colorectal cancer can be prevented or, if found early, treated and cured.
- According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests, could reduce death rates of colon cancer up to 66%.
- In 2016, only 73% of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19% had received a fecal occult blood test to screen for colorectal cancer.
- The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14%.
- In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women. African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country.
- Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost-effective than breast or prostate cancer screening.
This resolution designates March 2018 as Colorectal Cancer Awareness Month.
Comments
According to the author,
Colorectal cancer is often called the silent killer as symptoms caused by the cancer only show up in later stages of the disease. However, when it is detected at an early stage through proper screenings, the survival rate is 92%. As such, screenings are essential to the early detection, prevention and treatment of colorectal cancers.
Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost-effective than breast or prostate cancer screening which is why the American Cancer Society is committed to increasing screening rates to 80 percent by 2018. It is predicted that increasing screening rates to 80% by 2018 would reduce the rates of new colon cancer cases by 17% and death rates by 19% by the end of 2020. By 2030, colon cancer incidence rates would drop by 22% and death rates would drop by 33%. Those reductions add up to 277,000 new cancers and 203,000 colon cancer deaths prevented from 2013 through 2030.
By designating March as Colorectal Cancer Awareness Month, ACR 163 aims to draw awareness to the necessity for Californians to be proactive when it comes to their colorectal health and talk to their doctors about what the best colorectal cancer screening test for them. As the American Cancer Society Cancer Action Network (ACS CAN) states, “the best test is the one you have done now.”
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
American Cancer Society Cancer Action Network (co-source)
California Colorectal Cancer Coalition (co-source)
California Life Sciences Association
None received
Prepared by: Jonas Austin / SFA / (916) 651-1520
4/4/18 15:18:48
**** END ****
ASSEMBLY THIRD READING
ATR Bill Id:ACR 163
Author:(Flora and Baker)
As Amended Ver:February 21, 2018
Majority vote
Committee | Votes | Ayes | Noes |
Rules | 8-0 | Cooley, Carrillo, Cervantes, Fong, Grayson, Nazarian, Salas, Waldron |
SUMMARY: Designates March 2018 as Colorectal Cancer Awareness Month. Specifically, this resolution makes the following legislative findings:
- Colorectal cancer is the second leading cause of cancer deaths of Californians, with 14,400 new cases and 5,300 deaths expected in 2018. With proper screening, colorectal cancer can be prevented or, if found early, treated and cured.
- According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests, could reduce death rates of colon cancer up to 66%.
- In 2016, only 73% of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19% had received a fecal occult blood test to screen for colorectal cancer.
- The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14%.
- In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women. African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country.
- Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost-effective than breast or prostate cancer screening.
FISCAL EFFECT: None
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800 FN: 0002588
Date of Hearing: February 26, 2018
ASSEMBLY COMMITTEE ON
, Chair
ABPCA Bill Id:
Author:() – As Ver:
SUBJECT:
SUMMARY: Designates March 2018 as Colorectal Cancer Awareness Month. Specifically, this resolution makes the following legislative findings:
- Colorectal cancer is the second leading cause of cancer deaths of Californians, with 14,400 new cases and 5,300 deaths expected in 2018. With proper screening, colorectal cancer can be prevented or, if found early, treated and cured.
- According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests, could reduce death rates of colon cancer up to 66 percent.
- In 2016, only 73 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test to screen for colorectal cancer.
- The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent.
- In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women. African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country.
- Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost-effective than breast or prostate cancer screening.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
American Cancer Action Network
California Colorectal Cancer Coalition
Opposition
None on file
Analysis Prepared by:
Bill Author
Bill Co-Author(s):